This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (7)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

The Evolution of a Procedure

C. J. Tegtmeyer, MD

Arch Intern Med. 1982;142(6):1085-1087.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Renovascular hypertension, the type seen in approximately 4% of the hypertensive population in this country,¹ poses the double threat of severe hypertension (with its complications) and progressive renal insufficiency. Pharmacotherapy, surgical revascularization, or both, the traditional modes of treatment, have significant shortcomings. Drugs often only partially control blood pressure (BP); when several are used, side effects and poor patient compliance can become a problem.^2-4 Surgery requires general anesthesia, and many patients are poor risks because of severe diffuse atherosclerotic disease or renal insufficiency. Moreover, the results of surgery vary; there is considerable morbidity, and the mortality is 5.9%.⁵ Despite these shortcomings, therapy can have significant benefits.^6,7

A third therapeutic modality, percutaneous transluminal angioplasty (PTA), is presently undergoing evaluation. Percutaneous transluminal angioplasty is not a new procedure. It was originally developed by Dotter and Judkins⁸ for the treatment of atherosclerotic peripheral vascular disease. The procedure was . . . [Full Text PDF of this Article]

Author Affiliations
Department of Radiology School of Medicine University of Virginia Charlottesville, VA 22908

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?